This center supports the formulation or re-formulation of products, working with R&D teams of pharmaceutical companies globally. In May 2022, we open a new Closer to Formulator (C2F) Center of Excellence in India. Together with customers, suppliers and partners, we work towards the development of innovative products and transformative production methods, including 3D printing, Continuous Manufacturing and Biopharma solutions. In this partnership we are constantly developing new services to support our pharmaceutical and nutraceutical companies with technical expertise, as well as with supply-, time to market- and risk mitigation services, striving always towards 100% reliability in our supply and premium quality. More than just a supplier, we are a partner in every phase of the product development and delivery. So we can always be relied on the delivery of our products from one of our sites. To achieve this, we offer a Dual Sourcing system, meaning our products are produced at two different locations globally. We understand medicines and nutraceutical products are essential to patients and consumers and share our customers’ goal to deliver them in full and on time. We also offer a comprehensive range of ingredients for nutraceutical products, comprising lactose including milled-, sieved-, anhydrous-, spray dried- and granulated lactose-, MCC, superdisintegrants, starches and multifunctional co-processed excipients. Furthermore, we can customize the lactose to meet the specific needs of our customers. We also develop customized blended forms.Īs pioneers in the inhalation area, we produce a comprehensive range of lactose-based excipients, designed to offer the right characteristics for all inhaled medicines on the market. In the Biopharma field, our BioHale® portfolio is comprised by BioHale® Sucrose and BioHale® Trehalose Dihydrate, and can be used in various administration forms, such as for parenteral, inhalation, oral or ophthalmic route.įor Oral Solid Dose (OSD) formulations, we provide over 40 grades of milled-, sieved- and modified lactose, besides microcrystalline cellulose (MCC), superdisintegrants, starches and co-processed excipient solutions. We offer a wide range of over 200 premium products that play an essential role as fillers, binders, disintegrants, carriers and stabilizers. We differentiate ourselves as a excipients supplier of choice through our track record and well-known reputation for quality and consistency. Moving to a healthier world.Ī leading portfolio of premium quality excipients We provide our customers with our comprehensive technical expertise and support to efficiently navigate any regulatory space.ĭFE Pharma is committed to supporting (bio)pharmaceutical and nutraceutical companies in their journey to improve patients’ lives, driven by our purpose your medicines, our solutions. In our more than a century of heritage, we always work for customer satisfaction from formulation development support to excipient supply. ![]() ![]() Our excipients are used in numerous medicinal and nutraceutical products, including COVID-19 vaccines and treatments. We develop, produce and supply high-quality functional excipients for use in the pharmaceutical, biopharmaceutical, and nutraceutical industries for respiratory, oral solid dose (OSD), ophthalmic and parenteral formulations. DFE Pharma is a global leader in pharma- and nutraceutical excipient solutions.
0 Comments
Leave a Reply. |